Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04569240 · ClinicalTrials.gov registry record · NA
Accuracy of the Dexcom G6 Continuous Glucose Monitoring System Following Cardiac Surgery
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04569240 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 40 participants.
The verdict
NCT04569240, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a prospective longitudinal study to study the agreement between a novel continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the cardiovascular intensive care unit (CVICU), and by point of care glucose using the Accuchek Inform II on the regular floors, and the CGMS at the same time will be captured. Subjects will have measurements taken throughout their stay in the CVICU and on the regular floors.
Interventions
- DEVICE Dexcom G6 continuous glucose monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2024-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04569240
The ClinicalTrials.gov registry entry for NCT04569240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G6 continuous glucose monitor is the first listed.
NCT04569240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04569240 about?
NCT04569240 is a clinical study titled "Accuracy of the Dexcom G6 Continuous Glucose Monitoring System Following Cardiac Surgery". This is a prospective longitudinal study to study the agreement between a novel continuous glucose monitoring system (CGMS) versus current blood glucose monitoring. Subjects in this study will have their blood glucose measured regularly every 1-3 hours with current methods in the cardiovascular int...
What is the current status of trial NCT04569240?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-05-01. Estimated completion is 2024-07-01.
What interventions are being tested in trial NCT04569240?
The interventions under investigation include: Dexcom G6 continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT04569240?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.